当前位置:首页 - 行情中心 - 百洋医药(301015) - 财务分析

百洋医药

(301015)

  

流通市值:138.01亿  总市值:138.03亿
流通股本:5.26亿   总股本:5.26亿

百洋医药(301015)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.61亿元,每股收益0.91元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益276376.72万元,未分配利润162421.31万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产759143.64万元,负债482766.92万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入5,627,105,173.243,751,291,789.241,840,874,860.518,094,458,068.74
营业总成本4,964,392,143.683,428,066,346.851,635,496,471.037,169,337,235.28
其他经营收益
营业利润706,472,533.66265,699,374.41145,211,340.24977,737,964.01
利润总额695,288,726.28259,969,476.57143,254,109.6966,627,616.78
净利润560,613,786.74211,406,109.96109,662,899.99767,030,644.39
每股收益
其他综合收益-1,351,003.281,354,600.8628,024.82-104,993.07
综合收益总额559,262,783.46212,760,710.76110,290,924.81766,925,651.32
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,341,242,262.975,023,005,956.925,216,481,448.145,110,975,480.5
非流动资产:
非流动资产合计2,250,194,126.742,136,883,6802,086,416,459.582,001,608,770.63
资产总计7,591,436,389.717,159,889,636.927,302,897,907.727,112,584,251.13
流动负债:
流动负债合计3,441,378,304.63,330,990,823.983,354,576,985.413,257,963,613.64
非流动负债:
非流动负债合计1,386,290,913.961,386,127,561.751,234,378,391.871,249,949,031.86
负债合计4,827,669,218.564,717,118,385.734,588,955,377.284,507,912,645.5
所有者权益(或股东权益):
归属于母公司股东权益合计2,481,532,375.262,169,932,617.412,460,493,402.782,374,910,404.59
股东权益合计2,763,767,171.152,442,771,251.192,713,942,530.442,604,671,605.63
负债和股东权益合计7,591,436,389.717,159,889,636.927,302,897,907.727,112,584,251.13
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计6,420,978,563.774,420,362,102.212,106,729,811.898,764,150,968.68
经营活动现金流出小计5,799,560,998.564,028,597,444.811,806,739,127.87,950,300,563.79
经营活动产生的现金流量净额621,417,565.21391,764,657.4299,990,684.09813,850,404.89
投资活动产生的现金流量:
投资活动现金流入小计236,800,667.34136,069,442.8450,153,288.52398,660,782.45
投资活动现金流出小计766,370,662.08416,772,573.22252,012,575.921,130,979,506.36
投资活动产生的现金流量净额-529,569,994.74-280,703,130.38-201,859,287.4-732,318,723.91
筹资活动产生的现金流量:
筹资活动现金流入小计2,235,685,474.722,146,682,267.92711,385,385.492,199,793,250.95
筹资活动现金流出小计1,892,813,853.791,669,357,786.64446,144,717.862,195,127,583.98
筹资活动产生的现金流量净额342,871,620.93477,324,481.28265,240,667.634,665,666.97
汇率变动对现金及现金等价物的影响-6,340,154.17-3,208,683.17-1,701,430.832,205,432.12
现金及现金等价物净增加额428,379,037.23585,177,325.13361,670,633.4988,402,780.07
期末现金及现金等价物余额1,650,925,231.281,807,723,519.181,584,216,827.541,222,546,194.05
补充资料:
现金及现金等价物的净增加额-585,177,325.13-88,402,780.07
最新报告期:2025-09-19
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东方证券伍云飞0.911.531.962025-09-19
TOP↑